Moderna Inc. (0QF.F)
33.62
1.45 (4.51%)
At close: Jan 15, 2025, 1:26 PM
undefined% (undefined)
| Bid | n/a |
| Market Cap | 12.94B |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -5.67 |
| PE Ratio (ttm) | -5.93 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 550 |
| Avg. Volume (20D) | 1,882 |
| Open | 33.12 |
| Previous Close | 32.17 |
| Day's Range | 33.01 - 33.62 |
| 52-Week Range | 31.50 - 155.50 |
| Beta | undefined |
About 0QF.F
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus...
Industry Biotechnology
Sector Healthcare
IPO Date Dec 12, 2018
Employees 5,600
Stock Exchange XETRA
Ticker Symbol 0QF.F
Website https://www.modernatx.com